Clinical Trial Update: Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing two concentrations of CD1579 gel to vehicle for acne vulgaris, assessing efficacy and safety with results posted after study completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• CD1579 gel (concentration 1) (CD1579)
• CD1579 gel (concentration 2) (CD1579)

Snippet

Sponsor: Galderma R&D | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED | Results posted: 2016-11-03